Optimizing Anti-PD1 Immunotherapy: An Overview of Pharmacokinetics, Biomarkers, and Therapeutic Drug Monitoring

Joaquim Faria Monteiro, Alexandrina Fernandes, Diogo Gavina Tato, Elias Moreira, Ricardo Ribeiro, Henrique Reguengo, Jorge Gonçalves, Paula Fresco

Open source

DOI
10.3390/cancers17193262
Published
2025-10-08
Container
Cancers
Publisher
MDPI AG
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3390/cancers17193262,
  title = {Optimizing Anti-PD1 Immunotherapy: An Overview of Pharmacokinetics, Biomarkers, and Therapeutic Drug Monitoring},
  author = {Joaquim Faria Monteiro and Alexandrina Fernandes and Diogo Gavina Tato and Elias Moreira and Ricardo Ribeiro and Henrique Reguengo and Jorge Gonçalves and Paula Fresco},
  year = {2025},
  journal = {Cancers},
  doi = {10.3390/cancers17193262},
  url = {https://doi.org/10.3390/cancers17193262}
}

RIS

TY  - JOUR
TI  - Optimizing Anti-PD1 Immunotherapy: An Overview of Pharmacokinetics, Biomarkers, and Therapeutic Drug Monitoring
AU  - Joaquim Faria Monteiro
AU  - Alexandrina Fernandes
AU  - Diogo Gavina Tato
AU  - Elias Moreira
AU  - Ricardo Ribeiro
AU  - Henrique Reguengo
AU  - Jorge Gonçalves
AU  - Paula Fresco
PY  - 2025
JO  - Cancers
DO  - 10.3390/cancers17193262
UR  - https://doi.org/10.3390/cancers17193262
ER  - 

APA

Monteiro, J. F., Fernandes, A., Tato, D. G., Moreira, E., Ribeiro, R., Reguengo, H., Gonçalves, J., & Fresco, P. (2025). Optimizing Anti-PD1 Immunotherapy: An Overview of Pharmacokinetics, Biomarkers, and Therapeutic Drug Monitoring. Cancers. https://doi.org/10.3390/cancers17193262

Source records